
Alembic Pharma’s Karakhadi API facility in Gujarat gets an EIR from the USFDA
Last month that the Vadodara-based company announced that it had received approval for Bosutinib Tablets (Bosutinib Tablets, 100 mg and 500 mg), a drug used…

Last month that the Vadodara-based company announced that it had received approval for Bosutinib Tablets (Bosutinib Tablets, 100 mg and 500 mg), a drug used…

On the infrastructure front, BSE plans to add 200 more racks by the end of the financial year. These efforts are aimed at deepening and…

Mihir Vora, Chief Investment Officer of Trust Mutual Fund, noted that a steady stream of inflows from domestic sources like SIPs (systematic investment plans), pension…

In case MSN launches the generic version of the drug in July 2025, Divi’s Laboratories’ estimated earnings from Entresto API could be ₹700 crore in…

Marko Papic, Chief Strategist at BCA Research, expects oil prices to rise in the near term, driven largely by geopolitical risks centred around Iran. He…

Brokerage firm Morgan Stanley views this opening in Uttar Pradesh as a positive step and would closely track the company’s pace of expansion in the…

MobiKwik made a strong start to its journey as a public company, listing at a premium of 58% to its IPO price of ₹279. However,…

Brent crude surged over 4% on Tuesday (June 17) and stayed elevated through Asian trade on Wednesday (June 18). The gains came amid escalating tensions…

Promoters of Vishal Mega Mart sold stake worth nearly ₹10,500 crore on Tuesday, and India’s large domestic mutual funds, SBI MF, Kotak MF and HDFC…

The company said the five observations are procedural in nature. There was no observation related to data integrity reported, it added.